DMAAU
Drugs Made In-U·NASDAQ
--
--(--)
--
--(--)
6.45 / 10
Outperform
Technically, the stock benefits from bullish patterns such as Marubozu White and RSI Overbought, contributing to a 6.45/10 score. Although these signals are partially offset by other neutral factors, the technical backdrop remains supportive, hinting at potential short-term upside if momentum persists.
Analysis Checks(2/2)
RSI Overbought
Score6.41/10
Win Rate58.97%
Hist. Signals39
Avg Return0.13%
Score6.41/10
Win Rate58.97%
Hist. Signals39
Avg Return0.13%
Marubozu White
Score6.48/10
Win Rate59.46%
Hist. Signals37
Avg Return0.12%
Score6.48/10
Win Rate59.46%
Hist. Signals37
Avg Return0.12%
RSI Overbought
Score6.41/10
Win Rate58.97%
Hist. Signals39
Avg Return0.13%
Score6.41/10
Win Rate58.97%
Hist. Signals39
Avg Return0.13%
Marubozu White
Score6.48/10
Win Rate59.46%
Hist. Signals37
Avg Return0.12%
Score6.48/10
Win Rate59.46%
Hist. Signals37
Avg Return0.12%
Technical Analysis of DMAAU?
- DMAAU presents a Outperform setup with a Technical Score of 6.45/10. Key technical indicators highlight an RSI of 64.62 and a MACD of -0.00, with the trend anchored by the 50-Day SMA at 10.50. Traders should monitor key support at 10.55 and resistance at 10.55.
